PPARA and breast cancer: We found that RUNX2 knockdown increased epithelial markers and decreased mesenchymal marker expression, which was partially rescued via the co-knockdown of PPARα, indicating that RUNX2 could promote breast cancer cells invasion by repressing PPARα expression (Fig. 6A, C, Supplementary Fig. 6C).